中成药国家基本药物保障供应综合评估模型探索与研究.docVIP

中成药国家基本药物保障供应综合评估模型的探索与研究 　　[摘要] 中药价格暴涨暴跌，短期上涨对投料质量的影响不容忽视，另一方面，中药的生产严格受到资源的限制，许多中成药工业生产都因资源不足或禁用而被迫停止。该研究围绕《国家基本药物目录（2012年版）》中的203种中成药，通过分析影响中药基本药物供应的因素，设计了7个中药基本药物供应保障预警指标，基于中药资源普查和动态监测服务体系数据，提出了一种基于雷达图分析法的多指标综合评估模型，为中药基本药物的供应保障情况做出全局性、整体性的评价，评估结果简明、清晰、直观。以九味羌活丸和感冒清热颗粒为实例，验证了所提出的综合评估方法简明、清晰、直观、可信，具有实际意义。 　　[关键词] 中成药；国家基本药物；雷达图分析法；综合评估模型；预警指标 　　[Abstract] Chinese medicine prices often have sharp rise or fall， and even the impact of short-term price rise on the quality of feed can′t be ignored.On the other hand， the production of traditional Chinese medicine is strictly subject to resource constraints， so much of the industrial production due to lack of or prohibited use of resources must bestopped. Based on 203 Chinese patent medicines in the National Essential Drugs （2012 Edition）， the factors that influence the supply of essential drugs of traditional Chinese medicine were analyzed and seven indicators for the supply of essential medicines were designed in this paper. According to the Chinese herbal medicine resources survey and dynamic monitoring service system data， a multi-index comprehensive evaluation model based on radar chart analysis was proposed， providing a holistic and overall evaluation of the supply situation of essential drugs of traditional Chinese medicine. The evaluation results were concise， clear and intuitive. In this paper， Jiuwei Qianghuo Wan and Ganmao Qingre Keli were taken as the examples to prove that the proposed comprehensive evaluation method is concise， clear， intuitive， credible and practical. 　　[Key words] Chinese patent medicine；national essential drugs；radar chart analysis；comprehensive evaluation model；early-warning index 　　??家基本药物目录在保持数量相对稳定的基础上，实行动态调整管理，原则上每3年调整1次，必要时，经国家基本药物工作委员会审核同意，可适时组织调整[1]。《国家基本药物目录（2012年版）》目录中收录中成药共203个品种[2]，通过分析发现，这些中成药中涉及的中药资源种类有432种。 　　中药基本药物存在价格双轨制的问题，一方面原料价格是市场机制形成，另一方面中成药价格是政府定价。由于原料药材价格存在周期性剧烈波动甚至是不可逆的飙升，使得中成药成本不稳定甚至出现成本与最高零售限价倒挂，从而影响中成药的供应和用药安全。此外，中药供应还受资源存量的限制，单纯调查价格很难从根本上解决当前问题[3]。 　　通